COVID-19 (11,005 hospitalized patients during 2020–2021) | ||||||
---|---|---|---|---|---|---|
Death | HF | CKD | CRD | MI | Stroke | |
Number of events | 2025 | 229 | 234 | 442 | 63 | 97 |
T1D vs. T2D | 1.77 (1.41–2.22) | 2.57 (1.31–5.05) | 1.40 (0.68–2.85) | 1.83 (1.10–3.03) | 2.30 (0.71–7.46) | 1.86 (0.67–5.12) |
Age (per 10-year increase) | 2.17 (2.08–2.25) | 2.32 (2.03–2.64) | 1.40 (1.26–1.56) | 1.73 (1.59–1.89) | 1.64 (1.32–2.05) | 1.53 (1.29–1.83) |
Female sex | 0.76 (0.70–0.83) | 0.73 (0.56–0.96) | 0.84 (0.64–1.10) | 0.78 (0.64–0.95) | 1.00 (0.60–1.67) | 0.83 (0.55–1.26) |
Influenza (5111 hospitalized patients during 2015–2019) | ||||||
---|---|---|---|---|---|---|
Death | HF | CKD | CRD | MI | Stroke | |
Number of events | 247 | 353 | 201 | 525 | 85 | 98 |
T1D vs. T2D | 1.80 (1.26–2.57) | 1.15 (0.65–2.05) | 1.60 (0.95–2.68) | 1.43 (0.97–2.11) | 1.59 (0.61–4.16) | 1.50 (0.58–3.88) |
Age (per 10-year increase) | 1.86 (1.72–2.01) | 1.49 (1.34–1.66) | 0.96 (0.86–1.08) | 1.24 (1.14–1.35) | 1.34 (1.08–1.65) | 1.42 (1.16–1.74) |
Female sex | 0.92 (0.80–1.06) | 1.00 (0.81–1.24) | 0.99 (0.75–1.31) | 0.98 (0.82–1.16) | 0.72 (0.47–1.13) | 0.86 (0.58–1.29) |